WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009141249) USE OF NUCLEOTIDE FURANOSES AS AN AGENT FOR INHIBITING FURANOSYL TRANSFERASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/141249    International Application No.:    PCT/EP2009/055735
Publication Date: 26.11.2009 International Filing Date: 12.05.2009
IPC:
A61K 31/7052 (2006.01), A61K 31/7072 (2006.01), A61L 2/16 (2006.01), A61P 33/00 (2006.01)
Applicants: ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES [FR/FR]; 263 avenue du Général Leclerc F-35700 Rennes Cedex (FR) (For All Designated States Except US).
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE [FR/FR]; 74E rue de Paris F-35069 Rennes Cedex (FR) (For All Designated States Except US).
FERRIERES, Vincent [FR/FR]; (FR) (For US Only).
DANIELLOU, Richard [FR/FR]; (FR) (For US Only).
NUGIER-CHAUVIN, Caroline [FR/FR]; (FR) (For US Only).
PELTIER, Pauline [FR/FR]; (FR) (For US Only).
LOWARY, Todd [CA/CA]; (CA) (For US Only).
MIKUSOVA, Katarina [SK/SK]; (SK) (For US Only)
Inventors: FERRIERES, Vincent; (FR).
DANIELLOU, Richard; (FR).
NUGIER-CHAUVIN, Caroline; (FR).
PELTIER, Pauline; (FR).
LOWARY, Todd; (CA).
MIKUSOVA, Katarina; (SK)
Agent: LARCHER, Dominique; (FR)
Priority Data:
0853239 19.05.2008 FR
Title (EN) USE OF NUCLEOTIDE FURANOSES AS AN AGENT FOR INHIBITING FURANOSYL TRANSFERASES
(FR) UTILISATION DE NUCLEOTIDES-FURANOSES EN TANT QU'AGENT INHIBITEUR DE FURANOSYL TRANSFERASES
Abstract: front page image
(EN)The invention relates in particular to the use of particular nucleotide furanoses as agents for inhibiting furanosyl transferases. It also relates to the use of these compounds as a medicament, in particular in the prevention and/or treatment of diseases that can be improved or prevented by inhibiting furanosyl transferases.
(FR)L'invention concerne notamment l'utilisation de nucléotides-furanoses particuliers en tant qu'agents inhibiteurs de furanosyl transférases. Elle concerne également l'utilisation de ces composés en tant que médicament, en particulier dans la prévention et/ou le traitement de pathologies pouvant être améliorés ou évités par l'inhibition de furanosyl transférases.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: French (FR)
Filing Language: French (FR)